Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Valeo Pharma In-Play, New HesperCo™ Immune System Support Scientifically Demonstrated

Shares of Valeo Pharma Inc. (CSE: VPH) (Frankfurt: VP2) poised for substantial upside revaluation to reflect the major ‘company –maker’ potential in HesperCo™ as the market figures out it is set to be the subject of Covid-19 clinical trial. Valeo will benefit...
Fredrick William | September 2, 2020 |

Shaping the Future of Medicine by Delivering Regenerative Medicines

(Click image to play video) Envision a chest pain that feels like the most severe form of heartburn you ever experienced before. This is one of the main symptoms of ischemia – a disease which millions of people around the globe live with every day. Treati...
Dave Jackson | December 8, 2020 |

Biopharma Co. Makes Major Headway Toward Clinical Trials for Treatment of Stroke

(CLICK IMAGE TO PLAY VIDEO) Finding an effective method of preventing the possibility of stroke is something that medical science has grappled with for decades. Now, a Vancouver-based clinical stage biopharmaceutical development company looks to be making significa...
Dave Jackson | June 16, 2021 |

BioHarvest Sciences – Growing Exponentially

BioHarvest Sciences (CSNX: BHSC) is a rising star in the food, nutraceutical and cannabis industries. Through its intellectual property, it has developed a shortcut that could lead to cost savings and larger gross margins for its partners and future clients as well as a ...
Dr. Kal Kotecha | October 2, 2020 |

Shaping the Future of Regenerative Medicine Today

(Click image to play video) Hemostemix Inc. ( TSX-V: HEM , OTC: HMTXF , Forum ) is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. The Company’...
Dave Jackson | February 10, 2021 |

Bob Moriarty's Thoughts on the Coronavirus

If there was ever a time for real leaders to step forward and lead, the last four months would have been the time to do so. If there was an issue that demanded cooperation from all the nations of the world, we have seen it. Instead we have been fed a steady diet of disinf...
Streetwise Reports | April 20, 2020 |

Failed Breakouts Take a Heavy Toll on the Oil Bulls

The bulls certainly made a strong run yesterday but didn’t finish the day on a strong note in the least. That’s an understatement, actually. They’ve given up almost all of their gains, closing below the many important resistances...
Nadia Simmons | September 6, 2019 |

Trillion Energy’s (CSE:TCF) Bayhanli-2 gas well enters production

Trillion Energy International Inc. ( CSE: TCF ) ( OTCQB: TRLEF ) (Frankfurt: Z62) announced flow test results for the Bayhanli-2 natural gas well at the SASB gas field, offshore Turkey. Eight intervals of gas pay with a true thickness of about 21 metres were perfor...
Maor Kagan | June 1, 2023 |

Texas Oil & Gas Firm Reports Positive Mid-Q3/19 Operations Update

Accomplishments and revised estimates are reviewed in a ROTH Capital Partners report. In an Aug. 22 research note, analyst John White reported changes to ROTH Capital Partners' model on Ring Energy Inc. (REI:NYSE) . ROTH lowered its target price on the company to $...
Streetwise Reports | August 28, 2019 |

Proteostasis Therapeutics Reports Positive Results from European Cystic Fibrosis Research

Proteostasis Therapeutics' shares traded higher today after the company reported positive results in its European Cystic Fibrosis study of organoids grown from human stem cells. The firm believes the ongoing ex-vivo study supports initiation of a human clinical trial in mid-20...
Streetwise Reports | December 12, 2019 |
1 2 3 4 5 6 7 8 9 10 ...